Literature DB >> 25192990

Metabolic engineering of Acinetobacter baylyi ADP1 for improved growth on gluconate and glucose.

Matti Kannisto1, Tommi Aho2, Matti Karp2, Ville Santala2.   

Abstract

A high growth rate in bacterial cultures is usually achieved by optimizing growth conditions, but metabolism of the bacterium limits the maximal growth rate attainable on the carbon source used. This limitation can be circumvented by engineering the metabolism of the bacterium. Acinetobacter baylyi has become a model organism for studies of bacterial metabolism and metabolic engineering due to its wide substrate spectrum and easy-to-engineer genome. It produces naturally storage lipids, such as wax esters, and has a unique gluconate catabolism as it lacks a gene for pyruvate kinase. We engineered the central metabolism of A. baylyi ADP1 more favorable for gluconate catabolism by expressing the pyruvate kinase gene (pykF) of Escherichia coli. This modification increased growth rate when cultivated on gluconate or glucose as a sole carbon source in a batch cultivation. The engineered cells reached stationary phase on these carbon sources approximately twice as fast as control cells carrying an empty plasmid and produced similar amount of biomass. Furthermore, when grown on either gluconate or glucose, pykF expression did not lead to significant accumulation of overflow metabolites and consumption of the substrate remained unaltered. Increased growth rate on glucose was not accompanied with decreased wax ester production, and the pykF-expressing cells accumulated significantly more of these storage lipids with respect to cultivation time.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25192990      PMCID: PMC4249021          DOI: 10.1128/AEM.01837-14

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  27 in total

1.  Pathways for biosynthesis of a bacterial capsular polysaccharide. I. Carbohydrate metabolism and terminal oxidation mechanisms of a capsuleproducing coccus.

Authors:  W H TAYLOR; E JUNI
Journal:  J Bacteriol       Date:  1961-05       Impact factor: 3.490

2.  Reduction of aerobic acetate production by Escherichia coli.

Authors:  W R Farmer; J C Liao
Journal:  Appl Environ Microbiol       Date:  1997-08       Impact factor: 4.792

Review 3.  Opportunities for genetic investigation afforded by Acinetobacter baylyi, a nutritionally versatile bacterial species that is highly competent for natural transformation.

Authors:  David M Young; Donna Parke; L Nicholas Ornston
Journal:  Annu Rev Microbiol       Date:  2005       Impact factor: 15.500

Review 4.  Overcoming acetate in Escherichia coli recombinant protein fermentations.

Authors:  Mark A Eiteman; Elliot Altman
Journal:  Trends Biotechnol       Date:  2006-09-12       Impact factor: 19.536

5.  Characterization of growth and acid formation in a Bacillus subtilis pyruvate kinase mutant.

Authors:  B Fry; T Zhu; M M Domach; R R Koepsel; C Phalakornkule; M M Ataai
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

6.  Roles of pyruvate kinase and malic enzyme in Corynebacterium glutamicum for growth on carbon sources requiring gluconeogenesis.

Authors:  Roman Netzer; Malgorzata Krause; Doris Rittmann; Petra G Peters-Wendisch; Lothar Eggeling; Volker F Wendisch; Hermann Sahm
Journal:  Arch Microbiol       Date:  2004-09-15       Impact factor: 2.552

7.  Rewiring the wax ester production pathway of Acinetobacter baylyi ADP1.

Authors:  Suvi Santala; Elena Efimova; Perttu Koskinen; Matti Tapani Karp; Ville Santala
Journal:  ACS Synth Biol       Date:  2014-02-10       Impact factor: 5.110

8.  Aromatic degradative pathways in Acinetobacter baylyi underlie carbon catabolite repression.

Authors:  Rita Fischer; Fenja S Bleichrodt; Ulrike C Gerischer
Journal:  Microbiology       Date:  2008-10       Impact factor: 2.777

9.  Real-time monitoring of intracellular wax ester metabolism.

Authors:  Suvi Santala; Elena Efimova; Matti Karp; Ville Santala
Journal:  Microb Cell Fact       Date:  2011-09-30       Impact factor: 5.328

10.  Iterative reconstruction of a global metabolic model of Acinetobacter baylyi ADP1 using high-throughput growth phenotype and gene essentiality data.

Authors:  Maxime Durot; François Le Fèvre; Véronique de Berardinis; Annett Kreimeyer; David Vallenet; Cyril Combe; Serge Smidtas; Marcel Salanoubat; Jean Weissenbach; Vincent Schachter
Journal:  BMC Syst Biol       Date:  2008-10-07
View more
  6 in total

1.  Growth and wax ester production of an Acinetobacter baylyi ADP1 mutant deficient in exopolysaccharide capsule synthesis.

Authors:  Matti Kannisto; Elena Efimova; Matti Karp; Ville Santala
Journal:  J Ind Microbiol Biotechnol       Date:  2016-11-19       Impact factor: 3.346

2.  Improved fatty aldehyde and wax ester production by overexpression of fatty acyl-CoA reductases.

Authors:  Tapio Lehtinen; Elena Efimova; Suvi Santala; Ville Santala
Journal:  Microb Cell Fact       Date:  2018-02-08       Impact factor: 5.328

3.  Production of alkanes from CO2 by engineered bacteria.

Authors:  Tapio Lehtinen; Henri Virtanen; Suvi Santala; Ville Santala
Journal:  Biotechnol Biofuels       Date:  2018-08-21       Impact factor: 6.040

4.  Metabolic pairing of aerobic and anaerobic production in a one-pot batch cultivation.

Authors:  Milla Salmela; Tapio Lehtinen; Elena Efimova; Suvi Santala; Rahul Mangayil
Journal:  Biotechnol Biofuels       Date:  2018-07-03       Impact factor: 6.040

5.  Metabolic Engineering of the Shikimate Pathway for Production of Aromatics and Derived Compounds-Present and Future Strain Construction Strategies.

Authors:  Nils J H Averesch; Jens O Krömer
Journal:  Front Bioeng Biotechnol       Date:  2018-03-26

6.  Dynamic decoupling of biomass and wax ester biosynthesis in Acinetobacter baylyi by an autonomously regulated switch.

Authors:  Suvi Santala; Elena Efimova; Ville Santala
Journal:  Metab Eng Commun       Date:  2018-09-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.